Role of rituximab in the treatment of postpartum acquired haemophilia A: a systematic review of the literature (Q36187312)

12 August 2017

1 reference

title

Role of rituximab in the treatment of postpartum acquired haemophilia A: a systematic review of the literature (English)

1 reference

12 August 2017

0 references

0 references

1 reference

Massimo Franchini

1 reference

12 August 2017

Carlo Bonfanti

1 reference

12 August 2017

Silvia Crestani

series ordinal

1 reference

12 August 2017

Francesco Frattini

series ordinal

1 reference

12 August 2017

Cinzia Sissa

series ordinal

1 reference

12 August 2017

language of work or name

1 reference

17 December 2014

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

12 August 2017

396-400

1 reference

Inhibitor eradication with rituximab in haemophilia: where do we stand?

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Therapeutic challenges in acquired factor VIII deficiency

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Acquired inhibitors of coagulation factors: part I-acquired hemophilia A.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Management of acquired haemophilia A.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Recombinant activated factor VII: mechanisms of action and current indications

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

International recommendations on the diagnosis and treatment of patients with acquired hemophilia A

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Acquired factor VIII inhibitors

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Rituximab in the treatment of autoimmune haematological disorders

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Rituximab in the treatment of adult acquired hemophilia A: a systematic review

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

The efficacy of rituximab in the treatment of inhibitor-associated hemostatic disorders

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Postpartum acquired factor VIII inhibitors

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Acquired factor VIII inhibitors in pregnancy: data from the Italian Haemophilia Register relevant to clinical practice

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Postpartum acquired haemophilia: a single centre experience with rituximab

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Acquired haemophilia A: a 2013 update.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Single-center experience with rituximab as first-line immunosuppression for acquired hemophilia

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

A rapidly progressive, life-threatening postpartum hemorrhage: successful treatment with anti-CD-20 monoclonal antibody

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Successful response to rituximab in two cases of acquired haemophilia refractory to standard-therapy

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Efficacy of rituximab treatment in postpartum acquired haemophilia A.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Rituximab in postpartum-related acquired hemophilia

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Acquired hemophilia A in women postpartum: clinical manifestations, diagnosis, and treatment

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Postpartum acquired factor VIII inhibitors: results of a survey

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Severe intracranial hemorrhage in a newborn infant with transplacental transfer of an acquired factor VII:C inhibitor

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614290

Post-partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25545867

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Rituximab in the treatment of acquired factor VIII inhibitors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25545867

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Long-term response to rituximab in a patient with acquired hemophilia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25545867

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2450/2014.0242-14

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

25545867

1 reference